Cargando…
Blood-based gene expression profiling in castrate-resistant prostate cancer
Castrate-resistant prostate cancer (CRPC), the most life-threatening form of prostate cancer, has recently been the focus of many successful new treatments. Contemporary trials highlight the heterogeneous prognosis of CRPC as overall survival times vary greatly across different patient sub-groups. A...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568585/ https://www.ncbi.nlm.nih.gov/pubmed/26365516 http://dx.doi.org/10.1186/s12916-015-0463-8 |